ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352122 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352122; 2) Community: the network communities that were significantly associated with the response to NSC 352122; 3) Molecule: the relationships between components within communities and NSC 352122; 4) MDR: the compounds that were significantly associated with the NSC 352122.

NSC Compound Enrichment Correlation
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0278435641331424 0.78041881
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0278435641331424 0.78001572
NSC 289491 CHETOMIN 0.0278435641331424 0.030705576
NSC 347217 Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride 0.0278435641331424 0.50401511
NSC 10520 Null 0.0304779558345019 0.099375497
NSC 287459 Cytarabine AY 0.0304779558345019 0.52103762
NSC 58903 Null 0.0304779558345021 0.29767167
NSC 640506 1,4-Butanediamine, N-[4-(ethylamino)butyl]-N'-[4-[[4-(ethylamino)butyl]amino]butyl]-, pentahydrochloride 0.0304779558345021 0.058303041
NSC 668296 Null 0.0304779558345021 0.53228317
NSC 67588 2-Naphthacenecarboxamide, 4-dimethylamino-1,4,4a,5,5a,6,11,12a-pentahydroxy-N-[6-mercaptopurin-7(or 9)-ylmethyl]-6-methyl-1,11-dioxo- 0.0304779558345021 0.1247397
Total:67  Current:42    [First] [Prev] [Next] [Last]